nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC18A2—adrenal medulla—adrenal gland cancer	0.172	0.34	CbGeAlD
Amphetamine—CARTPT—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0999	0.202	CbGpPWpGaD
Amphetamine—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.07	0.138	CbGeAlD
Amphetamine—CARTPT—adrenal cortex—adrenal gland cancer	0.049	0.0967	CbGeAlD
Amphetamine—CARTPT—pituitary gland—adrenal gland cancer	0.0396	0.0781	CbGeAlD
Amphetamine—CARTPT—adrenal gland—adrenal gland cancer	0.0354	0.0698	CbGeAlD
Amphetamine—SLC22A3—Abacavir transmembrane transport—ABCB1—adrenal gland cancer	0.0341	0.0692	CbGpPWpGaD
Amphetamine—MAOB—Dopamine metabolism—PRKACA—adrenal gland cancer	0.0236	0.0479	CbGpPWpGaD
Amphetamine—CARTPT—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.0228	0.0463	CbGpPWpGaD
Amphetamine—CYP2D6—urine—adrenal gland cancer	0.021	0.0414	CbGeAlD
Amphetamine—SLC22A3—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	0.0196	0.0397	CbGpPWpGaD
Amphetamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—PRKACA—adrenal gland cancer	0.0157	0.0319	CbGpPWpGaD
Amphetamine—SLC18A2—adrenal gland—adrenal gland cancer	0.012	0.0237	CbGeAlD
Amphetamine—MAOB—adrenal cortex—adrenal gland cancer	0.011	0.0217	CbGeAlD
Amphetamine—TAAR1—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0109	0.022	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.01	0.0204	CbGpPWpGaD
Amphetamine—CYP2A6—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.01	0.0203	CbGpPWpGaD
Amphetamine—SLC22A3—gonad—adrenal gland cancer	0.00982	0.0194	CbGeAlD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00971	0.0197	CbGpPWpGaD
Amphetamine—MAOB—cardiac atrium—adrenal gland cancer	0.00908	0.0179	CbGeAlD
Amphetamine—MAOB—pituitary gland—adrenal gland cancer	0.00887	0.0175	CbGeAlD
Amphetamine—SLC22A5—adrenal cortex—adrenal gland cancer	0.00862	0.017	CbGeAlD
Amphetamine—SLC22A3—adrenal gland—adrenal gland cancer	0.00856	0.0169	CbGeAlD
Amphetamine—SLC6A2—gonad—adrenal gland cancer	0.00842	0.0166	CbGeAlD
Amphetamine—MAOB—adrenal gland—adrenal gland cancer	0.00792	0.0156	CbGeAlD
Amphetamine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00756	0.0153	CbGpPWpGaD
Amphetamine—DRD2—Nicotine Activity on Dopaminergic Neurons—PRKACA—adrenal gland cancer	0.00753	0.0153	CbGpPWpGaD
Amphetamine—DRD2—pituitary gland—adrenal gland cancer	0.00748	0.0148	CbGeAlD
Amphetamine—TAAR1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00739	0.015	CbGpPWpGaD
Amphetamine—SLC6A2—adrenal gland—adrenal gland cancer	0.00733	0.0145	CbGeAlD
Amphetamine—SLC22A5—cardiac atrium—adrenal gland cancer	0.00713	0.0141	CbGeAlD
Amphetamine—MAOB—Alpha-synuclein signaling—BAD—adrenal gland cancer	0.00697	0.0141	CbGpPWpGaD
Amphetamine—SLC22A5—pituitary gland—adrenal gland cancer	0.00697	0.0137	CbGeAlD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00677	0.0137	CbGpPWpGaD
Amphetamine—TAAR1—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00632	0.0128	CbGpPWpGaD
Amphetamine—SLC22A5—adrenal gland—adrenal gland cancer	0.00622	0.0123	CbGeAlD
Amphetamine—DRD2—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.00614	0.0125	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00581	0.0118	CbGpPWpGaD
Amphetamine—DRD2—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.00538	0.0109	CbGpPWpGaD
Amphetamine—CARTPT—Circadian rythm related genes—TP53—adrenal gland cancer	0.00521	0.0106	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—KCNJ5—adrenal gland cancer	0.00518	0.0105	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00518	0.0105	CbGpPWpGaD
Amphetamine—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00445	0.00902	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00443	0.00898	CbGpPWpGaD
Amphetamine—TAAR1—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00426	0.00863	CbGpPWpGaD
Amphetamine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—adrenal gland cancer	0.00424	0.0086	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00418	0.00847	CbGpPWpGaD
Amphetamine—SLC6A3—Alpha-synuclein signaling—BAD—adrenal gland cancer	0.00407	0.00824	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00403	0.00818	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00395	0.008	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00379	0.00769	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—KCNJ5—adrenal gland cancer	0.00309	0.00627	CbGpPWpGaD
Amphetamine—MAOB—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00307	0.00623	CbGpPWpGaD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00259	0.00526	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0025	0.00507	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00248	0.00502	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—GNAS—adrenal gland cancer	0.0023	0.00465	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.0023	0.00465	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00227	0.00461	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00226	0.00459	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00224	0.00454	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00223	0.00452	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00208	0.00422	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00203	0.00412	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00203	0.00411	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—PRKACA—adrenal gland cancer	0.00199	0.00403	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00196	0.00397	CbGpPWpGaD
Amphetamine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00185	0.00374	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00172	0.0035	CbGpPWpGaD
Amphetamine—MAOB—Biological oxidations—POMC—adrenal gland cancer	0.00163	0.00331	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—POMC—adrenal gland cancer	0.00155	0.00313	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00155	0.00313	CbGpPWpGaD
Amphetamine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.0015	0.00303	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SDHB—adrenal gland cancer	0.00146	0.00296	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00145	0.00295	CbGpPWpGaD
Amphetamine—CYP2A6—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00141	0.00287	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.0014	0.00285	CbGpPWpGaD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0014	0.00283	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00136	0.00275	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00136	0.00275	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00134	0.00272	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0013	0.00263	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SDHB—adrenal gland cancer	0.00123	0.0025	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00123	0.0025	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00123	0.00249	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00121	0.00245	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TSHR—adrenal gland cancer	0.0012	0.00243	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—PRKACA—adrenal gland cancer	0.00118	0.0024	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00118	0.00239	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MEN1—adrenal gland cancer	0.00112	0.00228	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—BRAF—adrenal gland cancer	0.00107	0.00217	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00107	0.00217	CbGpPWpGaD
Amphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00104	0.0021	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00103	0.00209	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000974	0.00198	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000964	0.00195	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—RRM1—adrenal gland cancer	0.00094	0.00191	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SDHD—adrenal gland cancer	0.00094	0.00191	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000924	0.00187	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000921	0.00187	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00092	0.00187	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000885	0.00179	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000884	0.00179	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000874	0.00177	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000866	0.00176	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000859	0.00174	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00085	0.00172	CbGpPWpGaD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000839	0.0017	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000833	0.00169	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—RRM1—adrenal gland cancer	0.000796	0.00161	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SDHD—adrenal gland cancer	0.000796	0.00161	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—POMC—adrenal gland cancer	0.000795	0.00161	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—POMC—adrenal gland cancer	0.000793	0.00161	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000749	0.00152	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000746	0.00151	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000735	0.00149	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000732	0.00148	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CDC42—adrenal gland cancer	0.000728	0.00148	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000719	0.00146	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SDHB—adrenal gland cancer	0.000711	0.00144	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IGF2—adrenal gland cancer	0.000702	0.00142	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MED12—adrenal gland cancer	0.000701	0.00142	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—GNAS—adrenal gland cancer	0.000696	0.00141	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000679	0.00138	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—BRAF—adrenal gland cancer	0.000638	0.00129	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000637	0.00129	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000595	0.00121	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MED12—adrenal gland cancer	0.000593	0.0012	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TERT—adrenal gland cancer	0.000584	0.00118	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000584	0.00118	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000583	0.00118	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000572	0.00116	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000535	0.00109	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00053	0.00107	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TP53—adrenal gland cancer	0.000524	0.00106	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000523	0.00106	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00052	0.00105	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000516	0.00105	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PRKACA—adrenal gland cancer	0.000511	0.00104	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—BAD—adrenal gland cancer	0.000508	0.00103	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000506	0.00103	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000486	0.000985	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000473	0.00096	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000472	0.000958	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—POMC—adrenal gland cancer	0.000469	0.00095	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—BRAF—adrenal gland cancer	0.000463	0.000938	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—RRM1—adrenal gland cancer	0.000458	0.000929	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SDHD—adrenal gland cancer	0.000458	0.000929	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000457	0.000926	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000449	0.000909	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000446	0.000904	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PRKACA—adrenal gland cancer	0.000433	0.000877	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GNAS—adrenal gland cancer	0.000414	0.00084	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ABCB1—adrenal gland cancer	0.000407	0.000825	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000399	0.000808	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	0.000361	0.000731	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GNAS—adrenal gland cancer	0.000351	0.000711	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ABCB1—adrenal gland cancer	0.000344	0.000698	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MED12—adrenal gland cancer	0.000342	0.000692	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000339	0.000687	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000334	0.000678	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	0.00032	0.000649	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000317	0.000642	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000313	0.000635	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000303	0.000613	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000288	0.000583	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000286	0.000581	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—POMC—adrenal gland cancer	0.000279	0.000566	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	0.000279	0.000566	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000275	0.000557	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EGFR—adrenal gland cancer	0.000265	0.000537	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	0.000262	0.000532	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000257	0.000521	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000257	0.000521	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	0.000249	0.000505	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—adrenal gland cancer	0.000236	0.000479	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—adrenal gland cancer	0.000223	0.000451	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TP53—adrenal gland cancer	0.000222	0.000451	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000204	0.000413	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GNAS—adrenal gland cancer	0.000202	0.000409	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.0002	0.000406	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	0.000198	0.000402	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000192	0.000388	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—adrenal gland cancer	0.000188	0.000382	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.000185	0.000375	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.00017	0.000344	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.000164	0.000332	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.000162	0.000329	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000158	0.000321	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.00014	0.000283	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.000136	0.000276	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—adrenal gland cancer	0.000136	0.000276	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000119	0.00024	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000113	0.00023	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000111	0.000225	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—adrenal gland cancer	0.000109	0.000222	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	0.000108	0.00022	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	0.000108	0.000219	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000105	0.000212	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	7.8e-05	0.000158	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—adrenal gland cancer	7.62e-05	0.000155	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	6.18e-05	0.000125	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	6.08e-05	0.000123	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TP53—adrenal gland cancer	5.19e-05	0.000105	CbGpPWpGaD
